Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03584048 · ClinicalTrials.gov registry record
Charlotte Retention in Care Study
A clinical trial of HIV I Infection, sponsored by Epividian.
- Completed
- Registry status
- 6,500
- Enrollment target
- 4
- Study locations
NCT03584048 is a study of HIV I Infection that has completed, run by Epividian. The registered enrollment target is 6,500 participants, above the 804-participant average among 5 other HIV I Infection trials with a reported enrollment target (708% higher). The trial reports 4 study locations across 1 state.
The verdict
NCT03584048, a study of HIV I Infection, has completed, sponsored by Epividian.
- COMPLETED
- Registry status
- 6,500 participants
- Enrollment target
- 4
- Study locations
Study Summary
The objective of the Charlotte Retention in Care study is to assess if clinical decision support systems (CDSS) that produce standardized alerts for measures of retention in care across clinics in the city of Charlotte, North Carolina have the ability to increase retention in care measures within clinics and in surveillance reports.
Conditions Studied
Interventions
- OTHER Alert to provider
Study Locations (4)
North Carolina
- Atrium Health - Charlotte
- Amity Group Foundation - Charlotte
- Ballantyne Family Medicine - Charlotte
- Rosedale Medical - Huntersville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,500 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2019-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03584048
The ClinicalTrials.gov registry entry for NCT03584048 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 804-participant average among 5 other HIV I Infection trials with a reported enrollment target (708% higher). The listed sponsor is Epividian, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV I Infection appearing as the primary indexed condition, and to 1 intervention - of which Alert to provider is the first listed.
NCT03584048 reports 4 study locations spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT03584048 about?
NCT03584048 is a clinical study titled "Charlotte Retention in Care Study". The objective of the Charlotte Retention in Care study is to assess if clinical decision support systems (CDSS) that produce standardized alerts for measures of retention in care across clinics in the city of Charlotte, North Carolina have the ability to increase retention in care measures within cl...
What is the current status of trial NCT03584048?
This trial is currently completed. The enrollment target is 6,500 participants. The study started on 2018-07-01. Estimated completion is 2019-10-31.
What conditions does trial NCT03584048 study?
This clinical trial studies the following conditions: HIV I Infection.
What interventions are being tested in trial NCT03584048?
The interventions under investigation include: Alert to provider (OTHER).
Who is sponsoring clinical trial NCT03584048?
This trial is sponsored by Epividian, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03584048 being conducted?
This trial has 4 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV I Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intervention to Improve HIV Care Retention by Addressing Stigma Stigmatized Environments
ACTIVE NOT RECRUITING · NA
-
To Investigate Safety, Reactogenicity and Immunogenicity of VIR-1388 Compared With Placebo in Participants Without HIV
COMPLETED · Phase 1
-
VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers
COMPLETED · Phase 1
-
Acute Effects of TCIG vs ECIG in PLWH
COMPLETED · NA
-
Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.